- Design
- Retrospective single-centre cohort
- Population
- 462 people with HLA-B27-associated acute anterior uveitis
- Primary outcome
- Time to complete control of anterior chamber inflammation
- Effect
- Median 28 vs 41 days; adjusted HR 2.19 (1.56–3.10)
This retrospective single-centre cohort included 462 people with HLA-B27-associated acute anterior uveitis seen between 2014 and 2025. At the first observed episode, 74 received topical corticosteroids plus oral prednisone and 388 topical steroids alone.
Median time to complete control of anterior chamber inflammation was 28 days with added prednisone versus 41 days with topical treatment alone. After adjustment, oral prednisone was the only variable associated with faster control (HR 2.19, 95% CI 1.56–3.10). Total time on treatment did not differ (62 vs 61 days). Prednisone for longer than 14 days gave no extra benefit. Starting with at least eight topical drops a day was associated with earlier discontinuation.
Since the sicker eyes probably received oral steroids, the true benefit may be larger than seen here. A short oral course, alongside intensive topical treatment from the start, is a reasonable option for a severe first attack — with blood glucose, blood pressure and TB risk considered before prescribing.
- Start intensive topical steroid at presentation, at least eight drops a day for a significant attack
- Consider a short oral prednisone course, up to 14 days, for severe HLA-B27 anterior uveitis
- Check glucose, blood pressure and TB risk before oral steroids
- Add cycloplegia and monitor intraocular pressure during treatment
- Ask about back pain, bowel and skin symptoms that suggest associated spondyloarthritis
Why it matters
Challenges the habit of reserving oral steroids for topical failure in acute anterior uveitis.
Don't overread it
A retrospective single-centre comparison; it does not prove oral steroids improve long-term visual outcome.
The statistics, in plain English
A hazard ratio of 2.19 means inflammation resolved at about twice the rate on any given day with added prednisone. The study was not randomised, and clinicians probably gave oral steroids to worse cases, which would bias against the oral group — so the benefit is unlikely to be overstated on that count, but other differences could still play a part.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free